BioCentury | Mar 12, 2020
Finance

March 11 Quick Takes: PDL, Kala, InnoCare, LifeSci, BioSight, BillionToOne, SEC

...and other undisclosed existing investors led the round, with participation from Y Combinator, Libertus Capital, Pacific 8 Ventures...
BioCentury | Nov 21, 2019
Financial News

Nov. 20 Financial Quick Takes: Diagnostics play Lucence raises series A; plus Novo-Broad, PMV, Phoenix, Winterlight and BMS-Celgene

A*STAR spinout Lucence raises $20M IHH led a $20 million series A round for Lucence, a blood-based cancer diagnostics company spun out of Singapore’s Agency for Science, Technology and Research (A*STAR) in 2016. The company...
BioCentury | Sep 29, 2008
Finance

Ebb & Flow

Sequenom (NASDAQ:SQNM) has more than quadrupled its market cap to $1.6 billion from $350 million since early June, when the company released initial data on its Down syndrome test. The $1.2 billion uptick equates to...
BioCentury | Jul 17, 2007
Financial News

Novocell raises $25 million

Novocell (San Diego, Calif.) raised $25 million in a series C round led by Johnson & Johnson Development Corp. Existing investors Sanderling; Asset Management; and Pacific Horizon Ventures also participated. Novocell's implantable PEG-encapsulated human pancreatic...
BioCentury | Jun 29, 2007
Financial News

Koronis raises $20 million

Koronis (Redmond, Wash.) raised $20 million in a series D round led by Pacific Horizon Ventures. Asset Management also participated. Koronis plans to complete two Phase IIa trials of KP-1461 to treat HIV infection in...
BioCentury | Oct 16, 2006
Company News

Amyris Biotechnologies Inc. board of directors update

Amyris Biotechnologies Inc. , Emeryville, Calif. Business: Biomanufacturing Appointed: Samir Kaul, general partner at Khosla Ventures; John Doerr, general partner at Kleiner Perkins Caufield & Byers; and Geoff Duyk, managing director at Texas Pacific Group Ventures...
BioCentury | Oct 9, 2006
Company News

Baxter, Texas Pacific Group Ventures Inc. deal

BAX will sell its Transfusion Therapies business to Texas Pacific for $540 million in cash. Assets in the deal include manual and automated blood-collection products, storage equipment and five manufacturing facilities. The business, which has...
BioCentury | May 16, 2005
Finance

Ebb & Flow

The Bank of New York has seen a big increase in the number of ex-U.S. biotech companies seeking Level I ADRs in order to get access to U.S. investors. The move is most likely being...
BioCentury | May 14, 2005
Financial News

Tranzyme raises $32M

Gastrointestinal company Tranzyme ( Research Triangle Park, N.C.) raised $32 million in a private round led by H.I.G. Ventures; Thomas, McNerney; and Quaker BioVentures. Other investors included Business Development Bank of Canada; Desjardins; Pacific Rim Ventures;...
BioCentury | Jan 10, 2005
Finance

Ebb & Flow

Last week saw two series D rounds go in opposite directions. Cancer play Nereus opted for a two-part financing, and maintains that having milestone-contingent money is important for discipline. On the flip side, drug delivery...
Items per page:
1 - 10 of 30
BioCentury | Mar 12, 2020
Finance

March 11 Quick Takes: PDL, Kala, InnoCare, LifeSci, BioSight, BillionToOne, SEC

...and other undisclosed existing investors led the round, with participation from Y Combinator, Libertus Capital, Pacific 8 Ventures...
BioCentury | Nov 21, 2019
Financial News

Nov. 20 Financial Quick Takes: Diagnostics play Lucence raises series A; plus Novo-Broad, PMV, Phoenix, Winterlight and BMS-Celgene

A*STAR spinout Lucence raises $20M IHH led a $20 million series A round for Lucence, a blood-based cancer diagnostics company spun out of Singapore’s Agency for Science, Technology and Research (A*STAR) in 2016. The company...
BioCentury | Sep 29, 2008
Finance

Ebb & Flow

Sequenom (NASDAQ:SQNM) has more than quadrupled its market cap to $1.6 billion from $350 million since early June, when the company released initial data on its Down syndrome test. The $1.2 billion uptick equates to...
BioCentury | Jul 17, 2007
Financial News

Novocell raises $25 million

Novocell (San Diego, Calif.) raised $25 million in a series C round led by Johnson & Johnson Development Corp. Existing investors Sanderling; Asset Management; and Pacific Horizon Ventures also participated. Novocell's implantable PEG-encapsulated human pancreatic...
BioCentury | Jun 29, 2007
Financial News

Koronis raises $20 million

Koronis (Redmond, Wash.) raised $20 million in a series D round led by Pacific Horizon Ventures. Asset Management also participated. Koronis plans to complete two Phase IIa trials of KP-1461 to treat HIV infection in...
BioCentury | Oct 16, 2006
Company News

Amyris Biotechnologies Inc. board of directors update

Amyris Biotechnologies Inc. , Emeryville, Calif. Business: Biomanufacturing Appointed: Samir Kaul, general partner at Khosla Ventures; John Doerr, general partner at Kleiner Perkins Caufield & Byers; and Geoff Duyk, managing director at Texas Pacific Group Ventures...
BioCentury | Oct 9, 2006
Company News

Baxter, Texas Pacific Group Ventures Inc. deal

BAX will sell its Transfusion Therapies business to Texas Pacific for $540 million in cash. Assets in the deal include manual and automated blood-collection products, storage equipment and five manufacturing facilities. The business, which has...
BioCentury | May 16, 2005
Finance

Ebb & Flow

The Bank of New York has seen a big increase in the number of ex-U.S. biotech companies seeking Level I ADRs in order to get access to U.S. investors. The move is most likely being...
BioCentury | May 14, 2005
Financial News

Tranzyme raises $32M

Gastrointestinal company Tranzyme ( Research Triangle Park, N.C.) raised $32 million in a private round led by H.I.G. Ventures; Thomas, McNerney; and Quaker BioVentures. Other investors included Business Development Bank of Canada; Desjardins; Pacific Rim Ventures;...
BioCentury | Jan 10, 2005
Finance

Ebb & Flow

Last week saw two series D rounds go in opposite directions. Cancer play Nereus opted for a two-part financing, and maintains that having milestone-contingent money is important for discipline. On the flip side, drug delivery...
Items per page:
1 - 10 of 30